# Statin Lowering Testosterone and Sexual Function

Study · id `cardio:ct-nct02612714` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02612714](<https://clinicaltrials.gov/study/NCT02612714>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02612714

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

## Technical summary

Registry record NCT02612714. Allocation not applicable; no masking. Start 2013-07 (registry gives no type); primary completion 2014-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking
- Phase: Phase 4
- Enrolled: 151 participants (enrolled count; ClinicalTrials.gov record NCT02612714, source copy `cardio:ctgov-nct02612714-2015-11-24`, retrieved 2026-10-26)
- Start date: 2013-07 (registry gives no type) (ClinicalTrials.gov record NCT02612714, source copy `cardio:ctgov-nct02612714-2015-11-24`, retrieved 2026-10-26)
- Primary completion: 2014-11 (actual) (ClinicalTrials.gov record NCT02612714, source copy `cardio:ctgov-nct02612714-2015-11-24`, retrieved 2026-10-26)
- Completion: 2014-12 (actual) (ClinicalTrials.gov record NCT02612714, source copy `cardio:ctgov-nct02612714-2015-11-24`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT02612714, source copy `cardio:ctgov-nct02612714-2015-11-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02612714-2015-11-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Statin Lowering Testosterone and Sexual Function
- Condition: Sexual Dysfunction
- Intervention (Drug): Rosuvastatin
- Lead sponsor: Chang Gung Memorial Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry intervention name matches this record: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Chang Gung Memorial Hospital (`cardio:org-chang-gung-memorial-hospital`)

## Provenance

Content hash: a05b2c5561b37860847cad143dfde3d91fc6539410d3686c12f5c3bb00a3aae2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
